Dianthus Therapeutics (Dianthus Therapeutics) ROE % Adjusted to Book Value : -8.61% (As of Mar. 2024)

Dianthus Therapeutics ROE % Adjusted to Book Value Chart

Competitive Comparison of Dianthus Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Dianthus Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dianthus Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dianthus Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Dianthus Therapeutics's ROE % Adjusted to Book Value falls into.

Dianthus Therapeutics ROE % Adjusted to Book Value Calculation

Dianthus Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

Dianthus Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dianthus Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Dianthus Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Dianthus Therapeutics (Dianthus Therapeutics) Business Description